|
US20160279239A1
(en)
|
2011-05-02 |
2016-09-29 |
Immunomedics, Inc. |
Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
|
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
CN105884893A
(zh)
|
2002-07-18 |
2016-08-24 |
莫鲁斯有限公司 |
抗体混合物的重组生产
|
|
WO2004106375A1
(en)
|
2003-05-30 |
2004-12-09 |
Merus Biopharmaceuticals B.V. I.O. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
|
CA2531684C
(en)
*
|
2003-07-22 |
2014-03-11 |
Crucell Holland B.V. |
Binding molecules against sars-coronavirus and uses thereof
|
|
CN102139106B
(zh)
|
2004-05-27 |
2014-10-08 |
克鲁塞尔荷兰公司 |
能中和狂犬病病毒的结合分子及其应用
|
|
EP1799259B1
(en)
*
|
2004-10-12 |
2012-12-05 |
Crucell Holland B.V. |
Binding molecules for the detection of cancer
|
|
US20160355591A1
(en)
|
2011-05-02 |
2016-12-08 |
Immunomedics, Inc. |
Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
|
|
US8052974B2
(en)
|
2005-05-12 |
2011-11-08 |
Crucell Holland B.V. |
Host cell specific binding molecules capable of neutralizing viruses and uses thereof
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
JP5574706B2
(ja)
*
|
2006-06-06 |
2014-08-20 |
クルセル ホランド ベー ヴェー |
ブドウ球菌に対する殺活性を有するヒトの結合分子及びその使用方法
|
|
EA017203B1
(ru)
|
2006-09-07 |
2012-10-30 |
Круселл Холланд Б.В. |
Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение
|
|
EP2125886A2
(en)
|
2007-03-13 |
2009-12-02 |
Humabs LLC |
Antibodies against h5n1 strains of influenza a virus
|
|
CA2680237C
(en)
|
2007-03-27 |
2018-11-06 |
Sea Lane Biotechnologies, Llc |
Constructs and libraries comprising antibody surrogate light chain sequences
|
|
US8542874B2
(en)
*
|
2007-07-11 |
2013-09-24 |
Cairos Technologies Ag |
Videotracking
|
|
US8444986B2
(en)
|
2007-09-13 |
2013-05-21 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof
|
|
SG183031A1
(en)
|
2007-09-13 |
2012-08-30 |
Temasek Life Sciences Lab Ltd |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
|
|
EP3524619A1
(en)
*
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
EP2698380A1
(en)
*
|
2008-03-28 |
2014-02-19 |
Sea Lane Biotechnologies, LLC |
Neutralizing molecules to viral antigens
|
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
|
RU2553325C2
(ru)
*
|
2008-07-25 |
2015-06-10 |
Институт Фо Ресёч Ин Биомедицин |
Нейтрализующие антитела против вируса гриппа а и их использование
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
GB0818356D0
(en)
*
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
|
TWI381848B
(zh)
*
|
2008-10-20 |
2013-01-11 |
Imclone Llc |
抗纖維母細胞生長因子受體-3 (fgfr-3) 抗體及包含其之醫藥組合物
|
|
NZ592036A
(en)
|
2008-10-22 |
2012-12-21 |
Inst Research In Biomedicine |
Methods for producing antibodies from plasma cells
|
|
CN102438652B
(zh)
*
|
2008-11-12 |
2014-08-13 |
米迪缪尼有限公司 |
抗体制剂
|
|
CN102292350A
(zh)
|
2008-12-24 |
2011-12-21 |
淡马锡生命科学研究院有限公司 |
对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途
|
|
EP3009145A1
(en)
|
2009-03-30 |
2016-04-20 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
|
CA2760553A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Jr. James E. Crowe |
Monoclonal antibodies to influenza h1n1 virus and uses thereof
|
|
WO2010130636A1
(en)
*
|
2009-05-11 |
2010-11-18 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
US20120128671A1
(en)
|
2009-05-13 |
2012-05-24 |
Lawrence Horowitz |
Neutralizing molecules to influenza viruses
|
|
JP5941841B2
(ja)
|
2009-05-26 |
2016-06-29 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用
|
|
US8974788B2
(en)
*
|
2009-08-14 |
2015-03-10 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
EP2486054A4
(en)
*
|
2009-10-09 |
2013-09-11 |
Univ Emory |
RECOMBINANT ANTIBODIES TO H1N1 INFLUENZA
|
|
JP6210685B2
(ja)
*
|
2010-01-27 |
2017-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
標的化された広域スペクトルのインフルエンザ中和のための操作されたポリペプチド剤
|
|
CA2790380A1
(en)
|
2010-02-18 |
2011-08-25 |
Mount Sinai School Of Medicine |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
EP2545074A4
(en)
*
|
2010-03-08 |
2014-01-08 |
Celltrion Inc |
HUMAN MONOCLONAL ANTIBODIES MADE FROM HUMAN B-CELLS WITH NEUTRALIZING EFFECT AGAINST INFLUENZA A-VIRUS
|
|
MX2012011300A
(es)
|
2010-03-30 |
2012-11-29 |
Sinai School Medicine |
Vacunas del virus de influenza y usos de las mismas.
|
|
CN102241768B
(zh)
*
|
2010-05-14 |
2013-12-25 |
中国科学院上海生命科学研究院 |
一种抗甲型h1n1流感病毒血凝素蛋白的抗体
|
|
CN106397584A
(zh)
*
|
2010-06-17 |
2017-02-15 |
特瑞利斯生物科学有限责任公司 |
可用于被动流感免疫的抗体
|
|
AU2011282423B2
(en)
|
2010-07-22 |
2015-05-14 |
Schrader, Sabariah |
Cross-protective pathogen protection, methods and compositions thereof
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2603237A4
(en)
*
|
2010-08-12 |
2014-05-21 |
Theraclone Sciences Inc |
ANTI-HEMAGGLUTININE ANTIBODY COMPOSITIONS AND METHOD FOR THEIR USE
|
|
US9534042B2
(en)
*
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
CA2811103C
(en)
|
2010-09-14 |
2020-01-14 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for influenza
|
|
RS63430B1
(sr)
|
2010-10-01 |
2022-08-31 |
Modernatx Inc |
Ribonukleinske kiseline koje sadrže n1-metil-pseudouracile i njihove primene
|
|
WO2012096994A2
(en)
*
|
2011-01-10 |
2012-07-19 |
Emory University |
Antibodies directed against influenza
|
|
CA2827301A1
(en)
*
|
2011-02-14 |
2012-08-23 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
AU2012223358A1
(en)
*
|
2011-03-01 |
2013-09-05 |
Amgen Inc. |
Sclerostin and DKK-1 bispecific binding agents
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
CA2831572C
(en)
*
|
2011-05-02 |
2019-11-26 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
AU2012273039B2
(en)
|
2011-06-20 |
2016-12-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for H1N1 influenza
|
|
US8961978B2
(en)
|
2011-07-14 |
2015-02-24 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
|
|
MX352338B
(es)
|
2011-07-18 |
2017-11-17 |
Inst Res Biomedicine |
Anticuerpos neutralizantes del virus de la influenza a y usos de estos.
|
|
WO2013016714A1
(en)
|
2011-07-28 |
2013-01-31 |
Sea Lane Biotechnologies |
Sur-binding proteins against erbb3
|
|
US20130084301A1
(en)
*
|
2011-08-30 |
2013-04-04 |
Steven Foung |
Cluster of Neutralizing Antibodies to Hepatitis C Virus
|
|
GB201115214D0
(en)
|
2011-09-02 |
2011-10-19 |
Health Prot Agency |
Influenza virus antibody compositions
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
AU2012312529B2
(en)
|
2011-09-20 |
2018-01-04 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
CA2791109C
(en)
|
2011-09-26 |
2021-02-16 |
Merus B.V. |
Generation of binding molecules
|
|
DK3682905T3
(da)
|
2011-10-03 |
2022-02-28 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf
|
|
EP2768858B1
(en)
|
2011-10-18 |
2018-08-01 |
Emory University |
Antibodies directed against influenza
|
|
WO2013079473A1
(en)
*
|
2011-11-28 |
2013-06-06 |
Crucell Holland B.V. |
Influenza virus vaccines and uses thereof
|
|
SG11201402780UA
(en)
|
2011-12-02 |
2014-10-30 |
Aimm Therapeutics Bv |
Influenza a virus specific antibodies
|
|
CA2861515A1
(en)
|
2011-12-05 |
2013-06-13 |
Trellis Bioscience, Llc |
Antibodies useful in passive influenza immunization
|
|
KR101749316B1
(ko)
|
2011-12-15 |
2017-06-21 |
(주) 에이프로젠 |
Ｈ１ｎ１―감염된 환자들로부터 유도된 매우 잠재력 있는 넓은-스펙트럼 중화 단일클론 항체 및 이를 포함하는 바이러스의 치료용 조성물
|
|
DE12858350T1
(de)
|
2011-12-16 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte mrna zusammensetzungen
|
|
US9975956B2
(en)
|
2011-12-22 |
2018-05-22 |
I2 Pharmaceuticals, Inc. |
Surrogate binding proteins which bind DR4 and/or DR5
|
|
BR112014018884A2
(pt)
|
2012-02-07 |
2017-07-04 |
Univ Pittsburgh Commonwealth Sys Higher Education |
antígenos amplamente reativos computacionalmente otimizados para viroses de influenza h3n2, h2n2, e b
|
|
MX359071B
(es)
|
2012-02-13 |
2018-09-13 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Antígenos ampliamente reactivos computacionalmente optimizados para influenza h5n1 humana y aviar.
|
|
US8834881B2
(en)
|
2012-03-08 |
2014-09-16 |
Crucell Holland B.V. |
Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
|
|
RU2639551C2
(ru)
|
2012-03-30 |
2017-12-21 |
Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн |
Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вирусов гриппа h5n1 и h1n1
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
HK1206601A1
(en)
|
2012-04-02 |
2016-01-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
PT2838917T
(pt)
|
2012-04-20 |
2019-09-12 |
Merus Nv |
Métodos e meios para a produção de moléculas similares a ig heterodiméricas
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
EP2712626A1
(en)
*
|
2012-09-28 |
2014-04-02 |
Fabentech |
Passive immunisation against influenza, in particular H5N1
|
|
BR112015010817A8
(pt)
|
2012-11-13 |
2018-01-23 |
Genentech Inc |
anticorpos anti-hemaglutinina isolado, método de tratamento, inibição ou prevenção de infecções, composição, composição farmacêutica, ácido nucleico isolado, célula hospedeira, método de produção de anticorpos e uso do anticorpo anti-hemaglutinina
|
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
|
SG11201503989PA
(en)
|
2012-11-27 |
2015-06-29 |
Univ Pittsburgh |
Computationally optimized broadly reactive antigens for h1n1 influenza
|
|
CN105263516A
(zh)
|
2012-12-18 |
2016-01-20 |
西奈山伊坎医学院 |
流感病毒疫苗及其用途
|
|
EP2970397A2
(en)
|
2013-03-14 |
2016-01-20 |
University Of Washington Through Its Center For Commercialization |
Polypeptides for treating and/or limiting influenza infection
|
|
JP6595448B2
(ja)
|
2013-03-14 |
2019-10-23 |
コントラフェクト コーポレイション |
治療効率の増強のために鼻腔内送達する中和抗体に基づく組成物および方法
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US9650434B2
(en)
|
2013-04-02 |
2017-05-16 |
Xiamen University |
Broad-spectrum monoclonal antibody recognizing HA1 domain of hemagglutinin of influenza virus
|
|
MX369317B
(es)
|
2013-05-30 |
2019-11-05 |
Janssen Vaccines & Prevention Bv |
Vacunas contra el virus de la influenza y sus usos.
|
|
EP3037819A4
(en)
*
|
2013-08-23 |
2017-03-29 |
Fujita Health University |
Method of determining resistance to influenza virus
|
|
WO2015025900A1
(ja)
|
2013-08-23 |
2015-02-26 |
学校法人藤田学園 |
抗インフルエンザウイルス中和抗体
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
RS60938B1
(sr)
|
2013-10-02 |
2020-11-30 |
Medimmune Llc |
Neutrališuća antitela na grip a i njihova upotreba
|
|
WO2015051214A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
EP3070167A4
(en)
*
|
2013-11-06 |
2017-06-07 |
Osaka University |
Antibody having broad neutralizing activity in group 1 influenza a virus
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
RU2720282C1
(ru)
|
2014-02-04 |
2020-04-28 |
Контрафект Корпорейшн |
Антитела, подходящие для пассивной иммунизации против гриппа, и их композиции, комбинации и способы применения
|
|
DK3105250T3
(da)
|
2014-02-10 |
2020-09-28 |
Igm Biosciences Inc |
Multispecifikke iga-bindingsmolekyler
|
|
AU2015231164B2
(en)
|
2014-03-19 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Immunogenetic restriction on elicitation of antibodies
|
|
DK3134131T3
(en)
|
2014-04-23 |
2022-02-07 |
Modernatx Inc |
Nucleic acid vaccines
|
|
MX378904B
(es)
|
2014-07-10 |
2025-03-10 |
Janssen Vaccines & Prevention Bv |
Vacunas para virus influenza y usos de las mismas.
|
|
SG11201610456UA
(en)
|
2014-07-10 |
2017-01-27 |
Janssen Vaccines & Prevention Bv |
Influenza virus vaccines and uses thereof
|
|
WO2016011035A2
(en)
|
2014-07-15 |
2016-01-21 |
Medlmmune, Llc |
Neutralizing anti-influenza b antibodies and uses thereof
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
CA2974699A1
(en)
|
2015-01-23 |
2016-07-28 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
|
US10174127B2
(en)
|
2015-02-05 |
2019-01-08 |
Janssen Vaccines & Prevention B.V. |
Human neutralizing antibodies binding to influenza neuraminidase
|
|
EA038407B1
(ru)
|
2015-02-05 |
2021-08-24 |
Янссен Вэксинс Энд Превеншн Б.В. |
Связывающие молекулы, направленные против гемагглютинина вируса гриппа, и пути их применения
|
|
BR112017024206A2
(pt)
|
2015-05-11 |
2018-07-17 |
Janssen Vaccines & Prevention Bv |
compostos peptidomiméticos neutralizadores do vírus da gripe
|
|
PT3303384T
(pt)
|
2015-06-01 |
2021-10-14 |
Medimmune Llc |
Moléculas de ligação neutralizantes anti-influenza e suas utilizações
|
|
WO2017083627A1
(en)
|
2015-11-13 |
2017-05-18 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
IL304940A
(en)
|
2016-01-13 |
2023-10-01 |
Medimmune Llc |
A method for treating type A influenza
|
|
CN109195629A
(zh)
|
2016-02-24 |
2019-01-11 |
威特拉公司 |
流行性感冒抗体分子制剂
|
|
WO2017148889A1
(en)
|
2016-03-01 |
2017-09-08 |
Janssen Vaccines & Prevention B.V. |
Human neutralizing antibodies binding to influenza b neuraminidase
|
|
BR112018075032A2
(pt)
|
2016-06-15 |
2019-03-26 |
Icahn School Of Medicine At Mount Sinai |
proteínas de hemaglutinina do vírus influenza e seus uso
|
|
KR101835009B1
(ko)
|
2016-08-19 |
2018-03-07 |
주식회사 하이딥 |
터치 입력 장치
|
|
JP7265984B2
(ja)
|
2016-10-21 |
2023-04-27 |
アディマブ， エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
|
AU2017345759B2
(en)
|
2016-10-21 |
2024-06-20 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
|
AU2017345786B2
(en)
*
|
2016-10-21 |
2024-08-01 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
|
US20200048308A1
(en)
|
2016-10-27 |
2020-02-13 |
Janssen Vaccines & Prevention B.V. |
Influenza virus neutralizing compounds
|
|
WO2018138681A1
(en)
|
2017-01-27 |
2018-08-02 |
National Research Council Of Canada |
Hemagglutinin-specific antibodies and uses thereof
|
|
US11040963B2
(en)
|
2017-02-02 |
2021-06-22 |
Janssen Vaccines & Prevention B.V. |
Piperazine derivatives for influenza virus inhibitions
|
|
WO2018141854A1
(en)
|
2017-02-02 |
2018-08-09 |
Janssen Vaccines & Prevention B.V. |
Piperazine derivatives for influenza virus inhibition
|
|
EP3579848B1
(en)
|
2017-02-08 |
2024-10-30 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
|
|
JP7685821B2
(ja)
|
2017-02-20 |
2025-05-30 |
ドラゴンフライ セラピューティクス， インコーポレイテッド |
Ｈｅｒ２、ＮＫＧ２ＤおよびＣＤ１６に結合するタンパク質
|
|
EP3606964A4
(en)
|
2017-04-03 |
2020-12-09 |
Immunomedics, Inc. |
SUBCUTANE ADMINISTRATION OF ANTIBODY DRUG CONJUGATES FOR CANCER THERAPY
|
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
KR102119783B1
(ko)
*
|
2017-08-14 |
2020-06-08 |
사회복지법인 삼성생명공익재단 |
인간 상피 성장 인자 수용체 변이체 ⅲ에 결합하는 항체 및 그의 항체 단편
|
|
JP7035170B2
(ja)
|
2017-09-15 |
2022-03-14 |
レンティジェン・テクノロジー・インコーポレイテッド |
抗ｃｄ１９免疫療法によりがんを処置するための組成物および方法
|
|
BR112020014343A2
(pt)
|
2018-01-23 |
2020-12-08 |
Janssen Vaccines & Prevention B.V. |
Vacinas contra o vírus da influenza e seus usos
|
|
US11780907B2
(en)
|
2018-01-26 |
2023-10-10 |
Regeneron Pharmaceuticals, Inc. |
Human antibodies to influenza hemagglutinin
|
|
MX2020008336A
(es)
|
2018-02-08 |
2020-09-21 |
Dragonfly Therapeutics Inc |
Dominios variables de anticuerpos que se dirigen al receptor nkg2d.
|
|
BR112020015994A2
(pt)
|
2018-02-08 |
2020-12-15 |
Dragonfly Therapeutics, Inc. |
Terapia de combinação do câncer que envolve proteínas de ligação multiespecíficas que ativam células natural killer
|
|
JP7353576B2
(ja)
|
2018-02-20 |
2023-10-02 |
ドラゴンフライ セラピューティクス， インコーポレイテッド |
Ｃｄ３３、ｎｋｇ２ｄ、及びｃｄ１６に結合する多重特異性結合タンパク質、ならびにその使用方法
|
|
US12364746B2
(en)
|
2018-06-21 |
2025-07-22 |
Icahn School Of Medicine At Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
EA202091888A1
(ru)
|
2018-08-08 |
2020-10-23 |
Драгонфлай Терапьютикс, Инк. |
Вариабельные домены антител, нацеленные на рецептор nkg2d
|
|
EA202190468A1
(ru)
|
2018-08-08 |
2021-07-06 |
Драгонфлай Терапьютикс, Инк. |
Мультиспецифические связывающие белки, которые связывают bcma, nkg2d и cd16, и способы их применения
|
|
SG11202101298XA
(en)
|
2018-08-08 |
2021-03-30 |
Dragonfly Therapeutics Inc |
Proteins binding nkg2d, cd16 and a tumor-associated antigen
|
|
CN111057718A
(zh)
*
|
2018-10-17 |
2020-04-24 |
南京大学 |
一种稳定表达绿色荧光蛋白的egfp-sp2/0细胞株及其构建方法
|
|
KR102113302B1
(ko)
*
|
2018-12-24 |
2020-05-20 |
원광대학교산학협력단 |
상보성결정부 기반 조류 인플루엔자 바이러스의 h5 아형에 특이적으로 결합하는 펩티드 및 이의 용도
|
|
CA3132521A1
(en)
|
2019-03-25 |
2020-10-01 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
AU2020342463A1
(en)
|
2019-09-05 |
2022-03-24 |
Janssen Vaccines & Prevention B.V. |
Influenza virus vaccines and uses thereof
|
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
|
CN111440228B
(zh)
*
|
2020-03-09 |
2021-08-24 |
扬州大学 |
多种亚型流感病毒ha2蛋白共同抗原表位、抗体、鉴定方法和应用
|
|
WO2021201677A1
(en)
|
2020-04-01 |
2021-10-07 |
Kiadis Pharma Intellectual Property B.V. |
Compositions and methods targeting influenza
|
|
US20210325367A1
(en)
*
|
2020-04-20 |
2021-10-21 |
Satish Mahna |
Controlled Exposure to Pathogens for Generating Immunity
|
|
AR122018A1
(es)
|
2020-05-06 |
2022-08-03 |
Dragonfly Therapeutics Inc |
Proteínas que se unen a nkg2d, cd16 y clec12a
|
|
CN116761605A
(zh)
*
|
2021-02-04 |
2023-09-15 |
四川海思科制药有限公司 |
Ha抑制剂化合物的盐及晶型
|
|
CN117222663A
(zh)
|
2021-03-03 |
2023-12-12 |
蜻蜓疗法股份有限公司 |
使用结合nkg2d、cd16和肿瘤相关抗原的多特异性结合蛋白治疗癌症的方法
|
|
TW202309075A
(zh)
*
|
2021-04-30 |
2023-03-01 |
美商亞得捷歐治療公司 |
對冠狀病毒s蛋白質具特異性之化合物及其用途
|
|
WO2024104947A2
(en)
|
2022-11-14 |
2024-05-23 |
Janssen Vaccines & Prevention B.V. |
Influenza b virus vaccines and uses thereof
|
|
WO2025019631A1
(en)
|
2023-07-19 |
2025-01-23 |
Icahn School Of Medicine At Mount Sinai |
Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof
|
|
TW202527960A
(zh)
|
2023-09-06 |
2025-07-16 |
美商賽諾菲巴斯德公司 |
經修飾ｂ型流感血球凝集素多肽及核酸及其用途
|
|
WO2025090499A1
(en)
*
|
2023-10-24 |
2025-05-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Monoclonal antibodies that bind an antigen of epithelial ovarian cancer and their use
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|